Shared decision making (SDM) plays a central role in managing kidney failure (KF) in many nephrology centres [1]. The progressive nature of KF underscores the need for continuous collaboration between patients and healthcare professionals, allowing personalized treatment choices as kidney function declines...
Chronic kidney disease (CKD) remains a widespread global health problem, affecting millions of people and posing significant challenges for both patients and healthcare providers. End stage renal disease (ESRD) is the terminal stage of CKD and more than 4 million patients with ESRD require the use...
Maintenance hemodialysis is the primary treatment for patients with Kidney Failure, and its successful implementation heavily relies on stable vascular access [1, 2]. The autologous arteriovenous fistula is typically the preferred choice for vascular access in hemodialysis patients [3]. However, central...
End-stage renal disease (ESRD) is a global health burden [1], and is associated with many health complications, necessitating renal replacement therapy through either kidney transplantation or hemodialysis [2]. Hemodialysis is one of the most efficient therapies and accounts for 89% of the worldwide...
Hemodialysis, a life-sustaining therapy for patients with end-stage renal disease, poses significant challenges in prognostication due to complications such as anemia, malnutrition, and vascular calcification that are prevalent among patients undergoing this treatment [1, 2]. These complications contribute...